Agency Forms Undergoing Paperwork Reduction Act Review, 56604-56605 [2017-25739]
Download as PDF
<![CDATA[
56604
Federal Register / Vol. 82, No. 228 / Wednesday, November 29, 2017 / Notices
[FR Doc. 2017–25722 Filed 11–28–17; 8:45 am]
BILLING CODE 6717–01–C
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–18–0214]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled National Health
Interview Survey (NHIS) to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on August
21, 2017. CDC received eight comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW.,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
National Health Interview Survey
(NHIS) (OMB Control Number 0920–
0214, Expiration Date 12/31/2019)—
Revision—National Center for Health
Statistics (NCHS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health
Service (PHS) Act (42 U.S.C.), as
amended, authorizes that the Secretary
of Health and Human Services (HHS),
acting through NCHS, shall collect
statistics on the extent and nature of
illness and disability of the population
of the United States.
The annual National Health Interview
Survey (NHIS) is a major source of
general statistics on the health of the
U.S. population and has been in the
field continuously since 1957. This
voluntary and confidential householdbased survey collects demographic and
health-related information from a
nationally-representative sample of
households and noninstitutionalized,
civilian persons throughout the country.
NHIS data have long been used by
government, academic, and private
researchers to evaluate both general
health and specific issues, such as
smoking, diabetes, health care coverage,
and access to health care. The survey is
also a leading source of data for the
Congressionally-mandated ‘‘Health US’’
and related publications, as well as the
single most important source of
statistics to track progress toward
Departmental health objectives.
The 2018 NHIS questionnaire remains
largely unchanged from its 2017
version, with the exception of new
supplements that are being added on
asthma and cancer control. These
supplements replace those from 2017 on
receipt of culturally and linguistically
appropriate health care services,
diabetes, epilepsy, cognitive disability,
complementary health, hepatitis B/C
screening, vision, and heart disease and
stroke prevention. Continuing from
2017 are supplemental questions about
access to and utilization of care and
barriers to care, disability and
functioning, family food security, ABCS
of heart disease and stroke prevention,
immunizations, smokeless tobacco and
e-cigarettes, and children’s mental
health.
In addition, in the last quarter of
2018, a portion of the regular 2018 NHIS
sample will be used to carry out a dress
rehearsal and systems test of the
redesigned NHIS questionnaire that is
scheduled for launch in January 2019.
The redesigned questionnaire revises
the NHIS both in terms of content and
structure in order to (1) improve the
measurement of covered health topics,
(2) reduce respondent burden by
shortening the length of the
questionnaire and seamlessly
integrating supplements, (3) harmonize
overlapping content with other federal
health surveys, (4) establish a long-term
structure of ongoing and periodic topics,
and (5) incorporate advances in survey
methodology and measurement.
As in past years, and in accordance
with the 1995 initiative to increase the
integration of surveys within the DHHS,
respondents to the 2018 NHIS will serve
as the sampling frame for the Medical
Expenditure Panel Survey. In addition,
a subsample of NHIS respondents and/
or members of commercial survey
panels may be identified to participate
in cognitive testing and methodological
projects, using web and/or mail survey
tools, that will inform the development
of new rotating and supplemental
content.
There is no cost to the respondents
other than their time. Clearance is
sought for three years, to collect data for
2018–2020, with an estimated
annualized burden of 47,735 hours.
pmangrum on DSK3GDR082PROD with NOTICES1
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Adult Household Member ...............................
Main Household Composition and Family
Core.
Main Adult Core .............................................
Main Child Core .............................................
Sample Adult ...................................................
Adult Family Member ......................................
VerDate Sep<11>2014
15:19 Nov 28, 2017
Jkt 241001
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
39,375
1
23/60
31,500
12,250
1
1
15/60
10/60
E:\FR\FM\29NON1.SGM
29NON1
56605
Federal Register / Vol. 82, No. 228 / Wednesday, November 29, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Type of respondents
Form name
Adult Family Member ......................................
Adult Household Member ...............................
Sample Adult ...................................................
Adult Family Member ......................................
Adult Family Member ......................................
Adult Family Member ......................................
Adult Family Member ......................................
Main Supplements .........................................
Redesigned Household Roster ......................
Redesigned Adult Questionnaire ...................
Redesigned Child Questionnaire ...................
Methodological Projects .................................
Main Reinterview Survey ...............................
Redesigned Reinterview Survey ....................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
considered. Electronic comments must
be submitted on or before January 29,
2018. The https://www.regulations.gov
electronic filing system will accept
comments until midnight Eastern Time
at the end of January 29, 2018.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
Food and Drug Administration
Electronic Submissions
[Docket No. FDA–2016–E–2181]
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
[FR Doc. 2017–25739 Filed 11–28–17; 8:45 am]
BILLING CODE 4163–18–P
Determination of Regulatory Review
Period for Purposes of Patent
Extension; XURIDEN
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or the Agency) has
determined the regulatory review period
for XURIDEN and is publishing this
notice of that determination as required
by law. FDA has made the
determination because of the
submission of an application to the
Director of the U.S. Patent and
Trademark Office (USPTO), Department
of Commerce, for the extension of a
patent which claims that human drug
product.
DATES: Anyone with knowledge that any
of the dates as published (in the
SUPPLEMENTARY INFORMATION section) are
incorrect may submit either electronic
or written comments and ask for a
redetermination by January 29, 2018.
Furthermore, any interested person may
petition FDA for a determination
regarding whether the applicant for
extension acted with due diligence
during the regulatory review period by
May 29, 2018. See ‘‘Petitions’’ in the
SUPPLEMENTARY INFORMATION section for
more information.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
pmangrum on DSK3GDR082PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
15:19 Nov 28, 2017
Jkt 241001
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
39,375
5,625
4,500
1,750
15,000
4,375
625
1
1
1
1
1
1
1
Average
burden per
response
(in hours)
20/60
5/60
39/60
27/60
20/60
5/60
5/60
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2016–E–2181 for ’’Determination of
Regulatory Review Period for Purposes
of Patent Extension; XURIDEN.’’
Received comments, those filed in a
timely manner (see ADDRESSES), will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with § 10.20 (21
CFR 10.20) and other applicable
disclosure law. For more information
about FDA’s posting of comments to
public dockets, see 80 FR 56469,
E:\FR\FM\29NON1.SGM
29NON1
]]>Agencies
[Federal Register Volume 82, Number 228 (Wednesday, November 29, 2017)]
[Notices]
[Pages 56604-56605]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-25739]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-18-0214]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled National Health Interview Survey (NHIS) to
the Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on August 21, 2017. CDC received
eight comments related to the previous notice. This notice serves to
allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW., Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
National Health Interview Survey (NHIS) (OMB Control Number 0920-
0214, Expiration Date 12/31/2019)--Revision--National Center for Health
Statistics (NCHS), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Section 306 of the Public Health Service (PHS) Act (42 U.S.C.), as
amended, authorizes that the Secretary of Health and Human Services
(HHS), acting through NCHS, shall collect statistics on the extent and
nature of illness and disability of the population of the United
States.
The annual National Health Interview Survey (NHIS) is a major
source of general statistics on the health of the U.S. population and
has been in the field continuously since 1957. This voluntary and
confidential household-based survey collects demographic and health-
related information from a nationally-representative sample of
households and noninstitutionalized, civilian persons throughout the
country. NHIS data have long been used by government, academic, and
private researchers to evaluate both general health and specific
issues, such as smoking, diabetes, health care coverage, and access to
health care. The survey is also a leading source of data for the
Congressionally-mandated ``Health US'' and related publications, as
well as the single most important source of statistics to track
progress toward Departmental health objectives.
The 2018 NHIS questionnaire remains largely unchanged from its 2017
version, with the exception of new supplements that are being added on
asthma and cancer control. These supplements replace those from 2017 on
receipt of culturally and linguistically appropriate health care
services, diabetes, epilepsy, cognitive disability, complementary
health, hepatitis B/C screening, vision, and heart disease and stroke
prevention. Continuing from 2017 are supplemental questions about
access to and utilization of care and barriers to care, disability and
functioning, family food security, ABCS of heart disease and stroke
prevention, immunizations, smokeless tobacco and e-cigarettes, and
children's mental health.
In addition, in the last quarter of 2018, a portion of the regular
2018 NHIS sample will be used to carry out a dress rehearsal and
systems test of the redesigned NHIS questionnaire that is scheduled for
launch in January 2019. The redesigned questionnaire revises the NHIS
both in terms of content and structure in order to (1) improve the
measurement of covered health topics, (2) reduce respondent burden by
shortening the length of the questionnaire and seamlessly integrating
supplements, (3) harmonize overlapping content with other federal
health surveys, (4) establish a long-term structure of ongoing and
periodic topics, and (5) incorporate advances in survey methodology and
measurement.
As in past years, and in accordance with the 1995 initiative to
increase the integration of surveys within the DHHS, respondents to the
2018 NHIS will serve as the sampling frame for the Medical Expenditure
Panel Survey. In addition, a subsample of NHIS respondents and/or
members of commercial survey panels may be identified to participate in
cognitive testing and methodological projects, using web and/or mail
survey tools, that will inform the development of new rotating and
supplemental content.
There is no cost to the respondents other than their time.
Clearance is sought for three years, to collect data for 2018-2020,
with an estimated annualized burden of 47,735 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Adult Household Member............. Main Household Composition 39,375 1 23/60
and Family Core.
Sample Adult....................... Main Adult Core............ 31,500 1 15/60
Adult Family Member................ Main Child Core............ 12,250 1 10/60
[[Page 56605]]
Adult Family Member................ Main Supplements........... 39,375 1 20/60
Adult Household Member............. Redesigned Household Roster 5,625 1 5/60
Sample Adult....................... Redesigned Adult 4,500 1 39/60
Questionnaire.
Adult Family Member................ Redesigned Child 1,750 1 27/60
Questionnaire.
Adult Family Member................ Methodological Projects.... 15,000 1 20/60
Adult Family Member................ Main Reinterview Survey.... 4,375 1 5/60
Adult Family Member................ Redesigned Reinterview 625 1 5/60
Survey.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-25739 Filed 11-28-17; 8:45 am]
BILLING CODE 4163-18-P
